Adma Biologics (ADMA) Cash from Investing Activities (QoQ) (2012 - 2025)
Adma Biologics (ADMA) Cash from Investing Activities (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Adma Biologics | 2.04 Bn | 1.95 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 98.08% |
| Sep 30, 2025 | -468.58% |
| Jun 30, 2025 | 46.46% |
| Mar 31, 2025 | -71.64% |
| Dec 31, 2024 | -150.46% |
| Sep 30, 2024 | 53.57% |
| Jun 30, 2024 | -0.13% |
| Mar 31, 2024 | -67.87% |
| Dec 31, 2023 | -85.87% |
| Sep 30, 2023 | 13.19% |
| Jun 30, 2023 | 55.17% |
| Mar 31, 2023 | 48.11% |
| Dec 31, 2022 | -10.88% |
| Sep 30, 2022 | 14.20% |
| Jun 30, 2022 | -38.63% |
| Mar 31, 2022 | 22.68% |
| Dec 31, 2021 | -31.80% |
| Sep 30, 2021 | 37.69% |
| Jun 30, 2021 | -74.07% |
| Mar 31, 2021 | 28.55% |